On September 10, 2021, Li, Xiaolin; Xie, Yonghua; Shi, Feng; Li, Zizhong; Wu, Yiqin; Ma, Xiaoyun; Zhang, Shimeng; Wu, Qian published a patent.SDS of cas: 445490-78-8 The title of the patent was Preparation of pyrrolidine integrin modulator as antitumor agents. And the patent contained the following:
Disclosed are a compound, and a racemate, a stereoisomer, a tautomer, an isotopic marker, a nitrogen oxide, a solvate, a polymorph, a metabolite, an ester, and a prodrug thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same, a preparation method therefor, and the medical use thereof. The experimental process involved the reaction of tert-Butyl 7-(2-hydroxyethyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxylate(cas: 445490-78-8).SDS of cas: 445490-78-8
The Article related to pyrrolidine preparation integrin modulator antitumor, Heterocyclic Compounds (One Hetero Atom): Pyrroles and Pyrrolizines and other aspects.SDS of cas: 445490-78-8
Referemce:
1,8-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N2 – PubChem